Stay updated on A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study record page displays a 403 Forbidden message and a Home link instead of the record content.
    Difference
    0.5%
    Check dated 2026-10-05T18:20:53.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    403 Forbidden error page is now displayed for the study record, with the 403 heading, basic site navigation, and footer visible. The page appears to replace the study content due to access restrictions.
    Difference
    18%
    Check dated 2026-09-21T22:17:14.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, reflecting a minor page update.
    Difference
    0.1%
    Check dated 2026-08-31T16:45:58.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a small page update. This does not alter the page's content or functionality.
    Difference
    0.1%
    Check dated 2026-08-10T10:39:41.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The page’s revision marker was updated from v3.6.3 to v3.6.4, signaling a new version of the page template; no study information or functionality appears affected.
    Difference
    0.1%
    Check dated 2026-07-27T05:58:37.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.2 to v3.6.3, replacing the previous revision. This reflects a small update to the page’s revision history without altering displayed study details.
    Difference
    0.1%
    Check dated 2026-07-05T13:43:21.000Z thumbnail image

Stay in the know with updates to A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial page.